Estudio del efecto de la nifedipina sobre las vias aereas en pacientes afectos de broncopatia obstructiva cronica

Madrigal Vilata, J.A.; Llopis Llombart, R.; Merino Sesma, J.; Muñoz Gil, J.; Insa Perez, L.; Lopez Merino, V.

doi:10.1016/S0300-2896(15)32209-2

Archivos de Bronconeumología

ISSN: 0300-2896

Archivos de Bronconeumologia is a scientific journal that preferentially publishes prospective original research articles whose content is based upon results dealing with several aspects of respiratory diseases such as epidemiology, pathophysiology, clinics, surgery, and basic investigation. Other types of articles such as reviews, editorials, a few special articles of interest to the society and the editorial board, scientific letters, letters to the Editor, and clinical images are also published in the Journal. It is a monthly Journal that publishes a total of 12 issues and a few supplements, which contain articles belonging to the different sections.

All the manuscripts received in the Journal are evaluated by the Editors and sent to expert peer-review while handled by the Editor and/or an Associate Editor from the team. The Journal is published monthly in English.

Manuscripts will be submitted electronically using the following web site: https://www.editorialmanager.com/ARBR/, link which is also accessible through the main web page of Archivos de Bronconeumologia.

Access to any published article, is possible through the Journal's web page as well as from PubMed, Science Direct, and other international databases. Furthermore, the Journal is also present in Twitter and Facebook. The Journal expresses the voice of the Spanish Respiratory Society of Pulmonology and Thoracic Surgery (SEPAR) as well as that of other scientific societies such as the Latin American Thoracic Society (ALAT) and the Iberian American Association of Thoracic Surgery (AICT).

Authors are also welcome to submit their articles to the Journal's open access companion title, Open Respiratory Archives.

Archivos de Bronconeumologia has received the new Impact Factor (JCR). The impact factor has risen from 6.333 in 2021 to 8 in the last evaluated year, 2022.
It is needed to be a member of SEPAR or have a subscription to access full texts of articles published last year. Abstracts are available for all visitors.

Indexed in:

Current Contents/Clinical Medicine, JCR SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, SCOPUS, IBECS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2022

Citescore

CiteScore measures average citations received per document published.

Citescore 2022

2.8

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2022

0.434

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2022

0.437

View more metrics

Open Access Option

Journal Information

Previous article | Next article

Vol. 21. Issue 1.

Pages 29-33 (January - February 1985)

More article options

Pages 29-33 (January - February 1985)

DOI: 10.1016/S0300-2896(15)32209-2

Full text access

Estudio del efecto de la nifedipina sobre las vias aereas en pacientes afectos de broncopatia obstructiva cronica

The effect of nifedipine on the airways in chronic obstructive bronchial disorders

Visits

3109

Download PDF

J.A. Madrigal Vilata, R. Llopis Llombart, J. Merino Sesma, J. Muñoz Gil, L. Insa Perez, V. Lopez Merino

Servicio de Cardiología. Hospital Clínico Universitario. Valencia

This item has received

3109 Visits

Article information

Abstract

Bibliography

Download PDF

Statistics

Hemos estudiado el efecto que la nifedipina, un antagonista de los canales lentos del calcio, ejerce sobre las vías aéreas, comparándolo con el ejercido por el salbutamol, habiendo encontrado que la nifedipina mejora ligeramente la obstrucción bronquial incrementándose la VC en 6,7% (P < 0,01), el FEV1 en 9,1% (P < 0,01), el MEF50%vc en 15,8% (P < 0,01), el MMFR en 19,7% (P < 0,05), el PEF en 8,5% (P < 0,05) y la conductancia específica de vías áreas en 39,9% (P < 0,01), y disminuyendo la resistencia de vías aéreas en 25,7% (P < 0,001).

Los resultados obtenidos no justifican el uso de la nifedipina como fármaco broncodilatador, pero sí la convierten en alternativa válida a otros fármacos que pueden estar contraindicados en casos en los que se asocia una patología respiratoria a otra cardiovascular.

Nifedipine, which interferes with the passage of calcium ions was compared to salbutamol for its effect on the airways in obstructive bronchial disorders.

Nifedipine was found to slightly improve bronchial obstruction by increasing VC by 6.7% (p < 0.01); FEV1 by 9.1% (p < 0.01); MEF50%vc by 15.8% (p < 0.01); MMRF by 19.7% (p < 0.05); PEF by 8.5% (p < 0.05) and specific airways flow by 39.9% (p < 0.01) while decreasing airways resistance by 25.7% (p < 0.001). These findings do not justify the use of nifedipine as a broncbodilator although it is a valid altemative in cases where there is concommitant respiratory and cardiovascular disorder and other agents are not viable.

Full text is only aviable in PDF

Bibliografia

[1.]

A. Leff.

Pathophysiology of asthmatic bronchoconstriction.

Chest, 81 (1982), pp. 224-229

Medline

[2.]

H. Herzog.

Fundamentos fisiopatológicos del tratamiento del asma.

Sandorama, 1 (1982), pp. 6-10

[3.]

J.M. González, R. Morice, K. Bloom, S. Akers, A.E. Raizner, P.M. Stevens.

Inhibition of airway reactivity by nifedipine in patients with coronary artery disease.

Am Rev Respir Dis, 127 (1983), pp. 155-157

http://dx.doi.org/10.1164/arrd.1983.127.2.155 | Medline

[4.]

K.R. Patel.

The effect of calcium antagonist, nifedipine, in exercise-induced asthma.

Clinical Allergy, 11 (1981), pp. 429-432

Medline

[5.]

J. Cerrina, A. Denjean, G. Alexandre, A. Lokhart, P. Duroux.

Inhibition of exercise-induced asthma by a calcium antagonist, nifedipine.

Am Rev Respir Dis, 123 (1981), pp. 156-160

http://dx.doi.org/10.1164/arrd.1981.123.2.156 | Medline

[6.]

J.C. Foreman, J.L. Mongar, B.D. Gomperts.

Calcium ionophores and movement of calcium ions following the physiological stimulus to a secretory process.

Nature, 245 (1973), pp. 249-251

Medline

[7.]

N. Himori, N. Taira.

Differential effects of calcium antagonistic vasodilators, nifedipine and verapamil, on the tracheal musculature and vasculature of the dog.

Br J Pharmacol, 68 (1980), pp. 595-597

Medline

[8.]

P.J. Barnes.

Calcium-channel blockers and asthma.

Thorax, 38 (1983), pp. 481-485

Medline

[9.]

A.B. Dubois, S.Y. Botelho, G.N. Bedell, R. Marsahall, J.H. Comroe Jr..

A rapid plethysmographic method for measuring thoracic gas volume. A comparison with a nitrogen washout method for measuring functional residual capacity in normal subjects.

J Clin Invest, 35 (1956), pp. 322-326

http://dx.doi.org/10.1172/JCI103281 | Medline

[10.]

A.B. Dubois, S.Y. Botelho, J.H. Comroe Jr..

A new method for measuring in man using a body plethysmograph: values in normal subjects and in patients with respiratory disease.

J Clin Invest, 35 (1956), pp. 327-335

http://dx.doi.org/10.1172/JCI103282 | Medline

[11.]

A. Bouhuys, K.P. Van de Woestijne.

Respiratory mechanics and dust exposure in byssinosis.

J Clin Invest, 49 (1970), pp. 106-111

http://dx.doi.org/10.1172/JCI106209 | Medline

[12.]

S.F. Bouh.

The use of expiratory forced flows for determinig response to bronchodilator drugs.

Chest, 62 (1972), pp. 534-539

Medline

[13.]

Commision de normalisation des epreuves respiratoires de la Haute Auctorité de la CECA, Luxembourg. Aide memoire pour la practique de l’examen de la fonction ventilatoire par la spirographie. Masson et cíe. Paris, 1961.

[14.]

R.M. Cherniack, M.B. Raber.

Normal standards for ventilatory function using an automated wedge spirometer.

Am Rev Respir Dis, 106 (1972), pp. 38-46

http://dx.doi.org/10.1164/arrd.1972.106.1.38 | Medline

[15.]

R. Amrein, R. Keller, H. Joos, H. Herzog.

Neue Normalwerte fur die Lungenfunktionsprufung mit der Ganzkorperplethismographie.

Deutsch Med Wrchs, 94 (1969), pp. 1785-1790

[16.]

A. Fleckenstein.

Specific pharmacology of calcium in myocardium, cardiac pacemakers and vascular smooth muscle.

Annu Rev Pharmacol Toxicol, 17 (1977), pp. 149-166

http://dx.doi.org/10.1146/annurev.pa.17.040177.001053 | Medline

[17.]

H. Refsum, K. Landmark.

The effect of calcium antagonist drug, nifedipine, on the mechanical and electrical activity of the isolated rat atrium.

Acta Pharmacol Toxicol, 37 (1975), pp. 369-376

[18.]

K.E. Andersson, I. Ingemarsson, U. Ulmsten, L. Wingerup.

Inhibition of prostaglandin-induced uterine activity by nifedipine.

Br J Obstet Gynaecol, 86 (1979), pp. 175-179

Medline

[19.]

A. Mostbeck, K. Partsch, L. Perlsch.

Extracardiac effects of nifedipine «Adalat»; measurement of liver blood flow in animals and humans of peripheral circulation in lower limbs.

New therapy of ischemic heart disease., pp. 303-310

[20.]

E. Mikkelsen, K.E. Andersson, O. Pedersen.

Verapamil and nifedipine inhibition of contraction induced by potassium and noradrenaline in human mesenteric arteries and veins.

Acta Pharmacol Toxicol (Kbh), 44 (1979), pp. 110-119

[21.]

G. Grun, A. Fleckenstein.

Die elektromechanische Entkoppelung der glatten Gefassmuskulatur als Grund prinzip der Coronardilatation durch (Bay 1040 nifedipine).

Arzneim Forsch, 22 (1972), pp. 334-344

[22.]

U. Weder, G. Grun.

Ca++ antagonistische elektromechanische Entkoppelung der glatten Gefassmuskulatur als Wirkuns prinzip vasodilatortorischer Nitroverbindungen. Nunyun Scmiede Bergs.

Arch Pharm (Weinheim), (1973), pp. 277-282

[23.]

M.T. Olivari, C. Bartorelli, A. Polese, P. Moruzzi, M. Guazzi.

Treatment of hypertension with nifedipine, a calcium antagonist agent.

Circulation, 59 (1979), pp. 1056-1062

Medline

[24.]

R.P. Rubin.

The role of the calcium in the release of neurotransmitter substances and hormones.

Pharmacol Rev, 22 (1970), pp. 389-428

Medline

[25.]

C.B. Wollheim, M. Kikuchi, A.E. Renold, W.G. Sharp.

The role of intracellular and extracellular calcium in glucose stimulated biphasic insulin release by rats islets.

J Clin Invest, 62 (1978), pp. 451-458

http://dx.doi.org/10.1172/JCI109146 | Medline

[26.]

D. Bonaduce, N. Ferrara, M. Postiglione, et al.

Effetti de la soministrazione acuta di un farmaco ad azione Ca++ antagonista sulla resistenze bronchiali in soggetti affetti da broncopneumatia crónica ostruttiva.

Boll Soc Ital Cardiol, 9 (1980), pp. 1515-1521

[27.]

S.S. Jaiprakas, J.N. Sahay, S.S. Chatterjee, G. McDonald.

Efficacy of nifedipine in the treatment of angina pectoris and chronic airways Obstruction.

Postgrad Med J, 56 (1980), pp. 624-628

Medline

[28.]

A.G. McDonald, C.G. Ingram, R.S. MacNeill.

The effect of propranolol on airway resistance.

Br J Anaesth, 39 (1967), pp. 919-926

Medline

[29.]